These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7731060)

  • 21. Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptor.
    Zhang MY; Feng Y; Wang Y; Dimitrov DS
    MAbs; 2009; 1(5):475-80. PubMed ID: 20065647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiproliferative and apoptotic effects of a specific anti-insulin-like growth factor I receptor single chain antibody on breast cancer cells.
    Motallebnezhad M; Younesi V; Aghebati-Maleki L; Nickho H; Safarzadeh E; Ahmadi M; Movassaghpour AA; Hosseini A; Yousefi M
    Tumour Biol; 2016 Nov; 37(11):14841-14850. PubMed ID: 27639384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody binding to a peptide but not the whole protein by recognition of the C-terminal carboxy group.
    Liang TC; Luo W; Hsieh JT; Lin SH
    Arch Biochem Biophys; 1996 May; 329(2):208-14. PubMed ID: 8638953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides.
    Hellmark T; Brunmark C; Trojnar J; Wieslander J
    Clin Exp Immunol; 1996 Sep; 105(3):504-10. PubMed ID: 8809141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of insulin-like growth factor I activity by novel antisera: potential structure/function interactions.
    Pell JM; Hill RA; Stewart CE; Weston CR; Flick-Smith HC
    Endocrinology; 2000 Feb; 141(2):741-51. PubMed ID: 10650956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
    Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D
    Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a rabbit antihuman mechano growth factor (MGF) polyclonal antibody against the last 24 amino acids of the E domain.
    Philippou A; Stavropoulou A; Sourla A; Pissimissis N; Halapas A; Maridaki M; Koutsilieris M
    In Vivo; 2008; 22(1):27-35. PubMed ID: 18396778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peptide derived from an extracellular domain selectively inhibits receptor internalization: target sequences on insulin and insulin-like growth factor 1 receptors.
    Naranda T; Goldstein A; Olsson L
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11692-7. PubMed ID: 9326672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunodominant epitope in a functional domain near the N-terminus of human granulocyte-macrophage colony-stimulating factor identified by cross-reaction of synthetic peptides with neutralizing anti-protein and anti-peptide antibodies.
    Beffy P; Rovero P; Di Bartolo V; Laricchia Robbio L; Dané A; Pegoraro S; Bertolero F; Revoltella RP
    Hybridoma; 1994 Dec; 13(6):457-68. PubMed ID: 7737670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping of the polypeptide chain organization of the main extracellular domain of the alpha-subunit in membrane-bound acetylcholine receptor by antipeptide antibodies spanning the entire domain.
    Atassi MZ; Mulac-Jericevic B; Ashizawa T
    Adv Exp Med Biol; 1994; 347():221-8. PubMed ID: 7526636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to synthetic peptides as probes for the binding site on the alpha subunit of the acetylcholine receptor.
    Neumann D; Gershoni JM; Fridkin M; Fuchs S
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3490-3. PubMed ID: 2582416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain.
    Yang CQ; Zhan X; Hu X; Kondepudi A; Perdue JF
    Endocrinology; 1996 Jul; 137(7):2766-73. PubMed ID: 8770896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A monoclonal antibody to the type 1 insulin-like growth factor and insulin receptors stimulates deoxyribonucleic acid synthesis in human and murine fibroblasts.
    Cara JF; Stuart CA; Furlanetto RW
    Endocrinology; 1988 Sep; 123(3):1341-7. PubMed ID: 2969801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor.
    Xiong L; Kasuya J; Li SL; Kato J; Fujita-Yamaguchi Y
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5356-60. PubMed ID: 1319060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group.
    Motté P; Alberici G; Ait-Abdellah M; Bellet D
    J Immunol; 1987 May; 138(10):3332-8. PubMed ID: 2437187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
    Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
    Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope mapping of alpha-transforming growth factor: evidence of an immunodominant region.
    Hazarika P; Dedman JR
    Life Sci; 1988; 42(24):2525-31. PubMed ID: 2453776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo.
    Doern A; Cao X; Sereno A; Reyes CL; Altshuler A; Huang F; Hession C; Flavier A; Favis M; Tran H; Ailor E; Levesque M; Murphy T; Berquist L; Tamraz S; Snipas T; Garber E; Shestowsky WS; Rennard R; Graff CP; Wu X; Snyder W; Cole L; Gregson D; Shields M; Ho SN; Reff ME; Glaser SM; Dong J; Demarest SJ; Hariharan K
    J Biol Chem; 2009 Apr; 284(15):10254-67. PubMed ID: 19211557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New site-directed polyclonal antibody maps N-terminus of occluded region of the non-transformed glucocorticoid receptor oligomer to within BUGR epitope.
    Shea WK; Cowens JW; Ip MM
    J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):433-47. PubMed ID: 1716970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.